Report found that four times as many patents are granted on the top ten drugs in the US, compared to Europe | Non-profit says that the US’ patent system is ‘broken’.
Authority carries out dawn raid at Novartis’ premises | Probe focuses on the alleged unlawful use of a skincare patent to bar competition
Malaria remains endemic in 91 countries representing half of the world’s population | Licence is key to allow rapid access to innovation for those who need it most.
Law firm McGuire Woods has hired IP litigators Michael Nutter and Merritt Westcott, for its Chicago and Houston offices, respectively.
Kansas-based company wins block on infringing plant-based albumins | Genetically programmed rice expresses human proteins used in immunotherapy drugs, gene therapies and vaccines.
Patent law firm EIP has opened a new regional hub in Stockholm, Sweden with a focus on the life sciences.
Deal set to enable faster use of artificial intelligence in drug discovery | Planned AI models to identify novel targets and establish biomarkers of disease.
Gilead had filed patent infringement proceedings lawsuit against five companies | Drug makers will receive non-exclusive licences starting from Halloween 2031.
A split Federal Circuit revived a 2017 jury verdict that Teva had infringed GSK drug | Israeli pharma firm warns of threat to availability of low-cost generic medicines.
Law firm Hogan Lovells has hired Chris Natkanski to its global regulatory and intellectual property, media, and technology practice group in Boston.